Research Project · Health
Dr. Robert F. Vizza Clinical Accelerator Initiative (CAI)
Lustgarten Foundationlustgarten.org (opens in a new tab)Catalog updated
- Amount
- $2,000,000
- Program type
- Research Project
- Field
- Health
- Eligible career stages
- Not listed
About this program
The Lustgarten Foundation’s Dr. Robert F. Vizza Clinical Accelerator Initiative supports innovative, collaborative clinical trial concepts that translate research discoveries into novel therapies for pancreatic cancer, typically providing up to $1.5–$2 million for as many as three years. Proposals should be supported by strong preclinical or clinical rationale and include deep translational analyses of therapeutic mechanisms and disease biology; incremental safety or dose-finding studies are not eligible. Applicants must hold an M.D., D.M.D., D.V.M., Ph.D., or equivalent, occupy a faculty or equivalent research position, and demonstrate relevant research leadership and potential for clinical impact; domestic and international nonprofit or public institutions may apply without citizenship restrictions. Letters of intent are due through ProposalCentral on November 2, 2026, with selected applicants advancing to a Translational Advisory Group presentation and potentially a full grant application.
In FundFit
FundFit names the researchers at your institution who match this program, and shows the eligibility rules, the announcement, and 27 similar programs in full.
Ask for a demo of this program The form opens already filled in.